PROFOUND MEDICAL CORP. Taxes Payable, Current
PROFOUND MEDICAL CORP. (PROF) had Taxes Payable, Current of $63.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-06
- 2026-06-30: Taxes Payable, Current $63.00K.
- 2026-03-31: Taxes Payable, Current $41.00K.
- 2025-12-31: Taxes Payable, Current $39.00K.
- 2025-09-30: Taxes Payable, Current $58.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $63.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $41.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $39.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $58.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |